SCA
ZBH icon

SAC Capital Advisors’s Zimmer Biomet ZBH Stock Holding History

SAC Capital Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-218,500
Closed -$20.1M – 1062
2014
Q1 		$20.1M Sell
218,500
-105,459
-33% -$9.72M 0.1% 265
2013
Q4 		$29.3M Sell
323,959
-79,428
-20% -$6.87M 0.17% 151
2013
Q3 		$32.2M Buy
403,387
+217,588
+117% +$17.1M 0.17% 157
2013
Q2 		$13.5M Buy
+185,799
New +$13.9M 0.07% 298

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
IIS
Ignis Investment Services Edinburgh, United Kingdom $29.9B AUM
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
IFP
Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

SAC Capital Advisors's ZBH Position: Q2 2014 in Review

SAC Capital Advisors sold out of Zimmer Biomet (ZBH) in Q2 2014, closing a stake of 218,500 shares — an estimated $20.1M sold.

SAC Capital Advisors first reported a position in ZBH in Q2 2013 and held it in 4 quarters. The position peaked at $32.2M in Q3 2013. 707 funds tracked by Wall St. Rank hold ZBH as of Q2 2014.

  • SAC Capital Advisors reported no remaining Zimmer Biomet position as of Q2 2014 after selling out during the quarter.
  • SAC Capital Advisors sold 218,500 Zimmer Biomet shares in Q2 2014, an estimated $20.1M.
  • SAC Capital Advisors first reported a position in Zimmer Biomet in Q2 2013 and held it in 4 quarters.
  • SAC Capital Advisors's Zimmer Biomet position peaked at $32.2M in Q3 2013.
  • 707 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2014.

Based on SAC Capital Advisors's 13F filing for Q2 2014.